Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology
Small interfering RNA (siRNA) can selectively suppress the expression of disease-causing genes, holding great promise in the treatment of human diseases, including malignant cancers. In recent years, with the development of chemical modification and delivery technology, several siRNA-based therapeut...
Main Authors: | Jinxing Huang, Kai Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/8/1586 |
Similar Items
-
Small interfering RNA : new research /
by: Yamada, Kaito, et al.
Published: (2009) -
Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
by: Qi Chang Zheng, et al.
Published: (2020-06-01) -
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
by: Qi Chang Zheng, et al.
Published: (2021-02-01) -
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
by: John C. Burnett, et al.
Published: (2013-01-01) -
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
by: Sepideh Mirzaei, et al.
Published: (2021-11-01)